Baird maintained an Outperform rating on Onyx Pharmaceuticals (NASDAQ: ONXX) and raised its price target to $99.00.

Commenting on ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE